|
Bolton medical, inc.(d/b/a terumo aortic), herein known as the "company", is submitting this report pursuant to 21 cfr part 803, has made reasonable efforts to obtain complete information, and has provided as much as is available to the company as of the submission date of this report.This report is based on information obtained by the company, which may not have been able to fully investigate or verify prior to the date the report was required by the regulations.Any required fields that are unpopulated are blank because the information is currently unknown, unavailable, or not applicable.This report does not constitute an admission or a conclusion by anyone that the device caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the certain regulations, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
"occlusion: on (b)(6) 2025, the treo stent-graft was implanted and preoperative ct showed no problems.However, about a year later, contrast-enhanced ct revealed occlusion in the leg stent-graft.The patient has no difficulties walking.The physician is considering performing a femoral-femoral bypass procedure in the near future.Operation type: unknown blood loss: unknown ancillary devices used: treo stent-grafts (28-b2-30-100u and 28-l2-17-100u) unknown whether image is available pre-case plan available (see the attached schema) unknown whether additional information will be able to be obtained.(tc# (b)(4).Patient outcome: "no health damage to the patient.".
|